Pharmaceuticals

A tornado that tore through eastern North Carolina and struck a large Pfizer pharmaceutical plant has damaged its drug storage facility but not its medicine production areas.

The Food and Drug Administration’s approval is viewed as groundbreaking, but many details still must be figured out.

The company says its factory near Rocky Mount, North Carolina, makes nearly 25% of Pfizer's sterile injectable medicines used in U.S. hospitals.

A quality-control crisis at an Indian pharmaceutical factory has left doctors and their patients with impossible choices as cheap, effective, generic cancer drugs go out of stock.

Indivior was accused of using illegal strategies to keep generic versions of the opioid-treatment medication Suboxone off the market. Several states, including Florida, sued the company, which denies wrongdoing.

Doctors and pharmacists in Florida aren't strangers to diminished inventories. Here's a closer look at the current shortage and how the state is managing.

New statistics detail the nation’s worsening tide of sexually transmitted infections, but health officials are hoping an old drug will help the fight.

The new study targets redfish found in waters from St. Augustine to Pensacola and builds on a similar survey released last year that also found bonefish contaminated with pharmaceuticals in the Keys and Biscayne Bay.

Doctors have no national standards on when to order urine tests to check whether adult ADHD patients are properly taking their medication. Some patients are subjected to much more frequent testing than others.

The Senate Health Policy Committee approved the bill, while the House Healthcare Regulation Subcommittee is slated to take up its version on Tuesday.

Drugmakers long ceased to be the only villain of the insulin price scandal. While Lilly is cutting the list price and others may follow, will other "parties" (i.e. pharmacy benefit managers) cause the cost to increase before it hits the pharmacy counter?

The moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.